Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Careers
  • Programs
    • Research
      • IMEDS
      • Post Market Research
      • RAISE
      • Real World Data
    • Antimicrobial Use Data in Food Animals
    • Expanded Access Navigator
    • Fellowship
    • Food & Nutrition
    • FDA Operational Evaluation
    • FDA Patient Listening Sessions
    • Improving Understanding of the FDA and FDA-Regulated Products
    • Substance Use Disorders
    • COVID-19 Hub
  • News and Events
    • 2023 Annual Public Meeting
    • Innovations in Regulatory Science Awards
    • News
    • Events
    • Publications
  • eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Careers
  • Programs
    • Research
      • IMEDS
      • Post Market Research
      • RAISE
      • Real World Data
    • Antimicrobial Use Data in Food Animals
    • Expanded Access Navigator
    • Fellowship
    • Food & Nutrition
    • FDA Operational Evaluation
    • FDA Patient Listening Sessions
    • Improving Understanding of the FDA and FDA-Regulated Products
    • Substance Use Disorders
    • COVID-19 Hub
  • News and Events
    • 2023 Annual Public Meeting
    • Innovations in Regulatory Science Awards
    • News
    • Events
    • Publications
  • eRequest

News

Breadcrumb

  1. Home
  2. News and Events
  3. In Brief - The Cancer Letter
  • facebook
  • twitter
  • email
  • print

In Brief - The Cancer Letter

  • Reagan-Udall receives $250,000 from Rockefeller Foundation for COVID-19 Diagnostics Evidence Accelerator

 

 

Read more

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube
© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA